Straits Times Index
3,260.22 -32.91 (-1.00%) Nikkei
37,890.96 -569.12 (-1.48%) Hang Seng
17,144.12 -57.15 (-0.33%) FTSE 100
8,040.38 -4.43 (-0.06%) Bitcoin USD
64,548.02 -2,216.61 (-3.32%) CMC Crypto 200
1,393.71 -30.39 (-2.13%)
Vetoquinol SA (0O1O.L)
| Previous close | 96.10 |
| Open | 0.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 141 |
| Market cap | 11.684M |
| Beta (5Y monthly) | 0.91 |
| PE ratio (TTM) | 0.19 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Vetoquinol: Availability of the 2023 Universal Registration Document
LURE, France, April 24, 2024--Regulatory News: On 24 April 2024, Vetoquinol (Paris:VETO) filed its 2023 Universal Registration Document with the Autorité des Marchés Financiers (AMF) in ESEF (European Single Electronic Format).
- Business Wire
Vetoquinol: 2023 Annual Results
LURE, France, March 20, 2024--Regulatory News: Vetoquinol (Paris:VETO):
- Business Wire
Vetoquinol: Annual Sales 2023: €529 Million
LURE, France, January 24, 2024--Regulatory News: Matthieu Frechin, Chairman and CEO of Vetoquinol (Paris:VETO), said: "In an animal health market with flat volumes, our 2023 sales reflect our company’s resilience and agility. Sales were driven by the strong performance of our Essentials products in the second half of the year; their sustained growth has enabled us to continue to improve our product mix and increase the efficiency of our operations. We are therefore actively pursuing the implemen
